| Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial CM Nutting, JP Morden, KJ Harrington, TG Urbano, SA Bhide, C Clark, ... The lancet oncology 12 (2), 127-136, 2011 | 1900 | 2011 |
| Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer U Mallick, C Harmer, B Yap, J Wadsley, S Clarke, L Moss, A Nicol, ... New England Journal of Medicine 366 (18), 1674-1685, 2012 | 747 | 2012 |
| A double-blind, placebo-controlled, randomised trial of active manuka honey and standard oral care for radiation-induced oral mucositis J Bardy, A Molassiotis, WD Ryder, K Mais, A Sykes, B Yap, L Lee, ... British Journal of Oral and Maxillofacial Surgery 50 (3), 221-226, 2012 | 150 | 2012 |
| Evidence for extrathyroidal formation of 3-iodothyronamine in humans as provided by a novel monoclonal antibody-based chemiluminescent serum immunoassay CS Hoefig, J Köhrle, G Brabant, K Dixit, B Yap, CJ Strasburger, Z Wu The Journal of Clinical Endocrinology & Metabolism 96 (6), 1864-1872, 2011 | 103 | 2011 |
| Monitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy KF Ho, T Marchant, C Moore, G Webster, C Rowbottom, H Penington, ... International Journal of Radiation Oncology* Biology* Physics 82 (3), e375-e382, 2012 | 102 | 2012 |
| First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PARSPORT … C Nutting, R A'Hern, MS Rogers, MA Sydenham, F Adab, K Harrington, ... Journal of Clinical Oncology 27 (18_suppl), LBA6006-LBA6006, 2009 | 99 | 2009 |
| Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck DJ Thomson, P Silva, K Denton, S Bonington, SK Mak, R Swindell, ... Head & neck 37 (2), 182-187, 2015 | 96 | 2015 |
| Evaluation of an automatic segmentation algorithm for definition of head and neck organs at risk D Thomson, C Boylan, T Liptrot, A Aitkenhead, L Lee, B Yap, A Sykes, ... Radiation Oncology 9, 1-12, 2014 | 93 | 2014 |
| Nasopharyngeal carcinoma–a retrospective review of demographics, treatment and patient outcome in a single centre RJ Colaco, G Betts, A Donne, R Swindell, BK Yap, AJ Sykes, NJ Slevin, ... Clinical Oncology 25 (3), 171-177, 2013 | 87 | 2013 |
| Cribriform-morular variant of papillary thyroid carcinoma: molecular characterization of a case with neuroendocrine differentiation and aggressive behavior J Cameselle-Teijeiro, LP Menasce, BK Yap, RJ Colaco, P Castro, ... American Journal of Clinical Pathology 131 (1), 134-142, 2009 | 82 | 2009 |
| PARSPORT trial management group. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised … CM Nutting, JP Morden, KJ Harrington, TG Urbano, SA Bhide, C Clark, ... Lancet Oncol 12 (2), 127-136, 2011 | 80 | 2011 |
| IMRT dose fractionation for head and neck cancer: variation in current approaches will make standardisation difficult KF Ho, JF Fowler, AJ Sykes, BK Yap, LW Lee, NJ Slevin Acta Oncologica 48 (3), 431-439, 2009 | 55 | 2009 |
| Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation M Azrif, NJ Slevin, AJ Sykes, R Swindell, BK Yap Radiotherapy and Oncology 89 (1), 105-113, 2008 | 49 | 2008 |
| Thyroid incidentalomas discovered on positron emission tomography CT scanning–Malignancy rate and significance of standardised uptake values R Brindle, D Mullan, BK Yap, A Gandhi European Journal of Surgical Oncology (EJSO) 40 (11), 1528-1532, 2014 | 48 | 2014 |
| Anaplastic thyroid cancer: the addition of systemic chemotherapy to radiotherapy led to an observed improvement in survival—a single centre experience and review of the literature NM Lowe, S Loughran, NJ Slevin, BK Yap The Scientific World Journal 2014 (1), 674583, 2014 | 44 | 2014 |
| No Adverse Affect in Clinical Outcome Using Low Preablation Diagnostic 131I Activity in Differentiated Thyroid Cancer: Refuting Thyroid-Stunning Effect BK Yap, B Murby The Journal of Clinical Endocrinology & Metabolism 99 (7), 2433-2440, 2014 | 35 | 2014 |
| Fundoplication with gastrostomy vs gastrostomy alone: a systematic review and meta-analysis of outcomes and complications BKY Yap, SA Nah, Y Chen, Y Low Pediatric surgery international 33, 217-228, 2017 | 34 | 2017 |
| Management of the compromised airway and role of tracheotomy in anaplastic thyroid carcinoma N Mani, K McNamara, N Lowe, S Loughran, BK Yap Head & Neck 38 (1), 85-88, 2016 | 34 | 2016 |
| Dose intensified hypofractionated intensity-modulated radiotherapy with synchronous cetuximab for intermediate stage head and neck squamous cell carcinoma DJ Thomson, KF Ho, L Ashcroft, K Denton, G Betts, KL Mais, K Garcez, ... Acta oncologica 54 (1), 88-98, 2015 | 30 | 2015 |
| Are serial bone scans useful for the follow‐up of clinically localized, low to intermediate grade prostate cancer managed with watchful observation alone? BK Yap, R Choo, G Deboer, L Klotz, C Danjoux, G Morton BJU international 91 (7), 613-617, 2003 | 28 | 2003 |
